Ledger.Open graph →
SEC Form D · Amendment · filed October 22, 2015

Ballantyne Therapeutics, Inc

Offering
$800K
Sold
$565K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CHARLOTTE, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Michael Roberts · Charlotte, NCExec · DirectorSimon Pedder · Charlotte, NCDirectorBrian E. Doxtator · Charlotte, NCDirectorDonald R. Reynolds · Charlotte, NCDirectorRobert Coneybeer · Boston, MAExec · DirectorJohn S. Dwyer · Boston, MADirectorSarena D. Burch · Cayce, SCExec · DirectorMaceo K. Sloan · Cayce, SCDirectorBrian E. Doxtator · Charlotte, NCDirectorDonald R. Reynolds · Charlotte, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗